<DOC>
	<DOC>NCT02725086</DOC>
	<brief_summary>A Randomized, Open-label, Two-way Crossover, Open-label Clinical Trial to Compare Pharmacokinetic/Pharmacodynamic Properties and Safety after Subcutaneous Administration of Leucostim速 and Neupogen速 in Healthy Adult Volunteers</brief_summary>
	<brief_title>Evaluation of Pharmacokinetic/Pharmacodynamic Properties and Safety of Leucostim速 Compared to Neupogen速 in Healthy Adult Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Lenograstim</mesh_term>
	<criteria>Age 19 45 years BMI 18.5 25.0 kg/m2 Value of ANC(absolute neutrophil count) had to be inside the normality range at the screening Subjects with a history or presence of clinically relevant hypersensitivity reaction to investigational drugs (GCSF) or their ingredients/additives Subjects with a clinically relevant history of allergic reaction Subjects with a history of acute infectious diseases within 2 weeks prior to administration of investigational products At the investigator's discretion, subjects who is considered inappropriate to participate in the study due to any conditions including screening results</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>